Kancera goes after COVID-19 with fractalkine inhibitor May 20, 2020 By Cormac Sheridan No Comments DUBLIN – Kancera AB is the latest contender to reposition a clinical-stage small molecule with an immunomodulatory mechanism as a drug candidate for COVID-19. Read More